[The use of thienam for the emergency antibacterial therapy of acute suppurative pyelonephritis].
Results of a clinical and microbiological investigation designed to study thienam permit recommending this drug as an urgent agent of choice in acute purulent pyelonephritis. The drug is well tolerated. Among other benefits is extremely high sensitivity of bacteria (pathogenic and conditionally pathogenic) to the medication, achievement of an expected clinical effect within a short time since its therapy institution.
Pasiechnikov
S P
SP
Pohrebyns'kyĭ
V M
VM
Rudenko
A V
AV
Mitchenko
M V
MV
D000038:Abscess / Q000188:drug therapy; D000208:Acute Disease; D015377:Cilastatin / Q000627:therapeutic use; D000077728:Cilastatin, Imipenem Drug Combination; D004338:Drug Combinations; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D004630:Emergencies; D005260:Female; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D008297:Male; D011704:Pyelonephritis / Q000188:drug therapy* / Q000382:microbiology; D013997:Time Factors
D004338:Drug Combinations; D015377:Cilastatin; D015378:Imipenem; D000077728:Cilastatin, Imipenem Drug Combination